
Jasmohan Bajaj, MD, MS, joins Nancy Reau, MD, and Kimberly Brown, MD, on who to screen for HE in clinic and how to prepare patients and families.
Check out expert perspectives on semaglutide’s FDA approval for MASH and new research on PBC, infectious disease screening, and more in this August 2025 recap.
August 2025 brought a major milestone in hepatology with the FDA approval of semaglutide (Wegovy) 2.4 mg for adults with noncirrhotic






